Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin

Biochemical Pharmacology

Volumn 87, Issue 4, 2014, Pages 562-570

  Zhang, Y ^a   Yang, W Q ^a   Zhu, H ^e   Qian, Y Y ^a   Zhou, L ^a   Ren, Y J ^a   Ren, X C ^d   Zhang, L ^a   Liu, X P ^c   Liu, C G ^c   Ming, Z J ^a   Li, B ^e   Chen, B ^a   Wang, J R ^a   Liu, Y B ^b   Yang, J M ^a,d  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Anaplastic thyroid cancer; Apoptosis; Autophagy; Beclin1; Cisplatin; miR 30d

Indexed keywords

ANAPLASTIC THYROID CANCER; APOPTOSIS; AUTOPHAGY; BECLIN1; CISPLATIN; MIR-30D;

3' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; CISPLATIN; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICRORNAS; PROTEIN BINDING; THYROID NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84893808368     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.12.004     Document Type: Article

References (30)

1. A.R. Shaha Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer Laryngoscope 114 2004 393 402 (Pubitemid 38391898)
2. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, and H.R. Menck A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995 [see comments] Cancer 83 1998 2638 2648 (Pubitemid 29019586)
3. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
4. C. Quintavalle, E. Donnarumma, M. Iaboni, G. Roscigno, M. Garofalo, and G. Romano et al. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells Oncogene 2012
5. A. Baraniskin, K. Birkenkamp-Demtroder, A. Maghnouj, H. Zollner, J. Munding, and S. Klein-Scory et al. MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL Carcinogenesis 33 2012 732 739
6. A. Gaziel-Sovran, M.F. Segura, R. Di Micco, M.K. Collins, D. Hanniford, and E. Vega-Saenz de Miera et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis Cancer Cell 20 2011 104 118
7. D. Xu, F. Takeshita, Y. Hino, S. Fukunaga, Y. Kudo, and A. Tamaki et al. miR-22 represses cancer progression by inducing cellular senescence J Cell Biol 193 2011 409 424
8. J. Yao, L. Liang, S. Huang, J. Ding, N. Tan, and Y. Zhao et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma Hepatology 51 2010 846 856
9. N. Kobayashi, H. Uemura, K. Nagahama, K. Okudela, M. Furuya, and Y. Ino et al. Identification of miR-30d as a novel prognostic maker of prostate cancer Oncotarget 3 2012 1455 1471
10. S. Schwertheim, S.Y. Sheu, K. Worm, F. Grabellus, and K.W. Schmid Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma Horm Metab Res 41 2009 475 481
11. R. Visone, P. Pallante, A. Vecchione, R. Cirombella, M. Ferracin, and A. Ferraro et al. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas Oncogene 26 2007 7590 7595 (Pubitemid 350207711)
12. S. Marton, M.R. Garcia, C. Robello, H. Persson, F. Trajtenberg, and O. Pritsch et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis Leukemia 22 2008 330 338 (Pubitemid 351250538)
13. F. Esposito, M. Tornincasa, P. Pallante, A. Federico, E. Borbone, and G.M. Pierantoni et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2 J Clin Endocrinol Metab 97 2012 E710 E718
14. J. Kim, and D.J. Klionsky Autophagy, cytoplasm-to-vacuole targeting pathway, and pexophagy in yeast and mammalian cells Annu Rev Biochem 69 2000 303 342
15. H. Zhu, H. Wu, X. Liu, B. Li, Y. Chen, and X. Ren et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells Autophagy 5 2009 816 823
16. Y. Cheng, X. Ren, Y. Zhang, R. Patel, A. Sharma, and H. Wu et al. eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206 Cancer Res 71 2011 2654 2663
17. Y. Zhang, Y. Cheng, X. Ren, L. Zhang, K.L. Yap, and H. Wu et al. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response Oncogene 31 2012 1055 1064
18. X. Yang, X. Zhong, J.L. Tanyi, J. Shen, C. Xu, and P. Gao et al. mir-30d Regulates multiple genes in the autophagy pathway and impairs autophagy process in human cancer cells Biochem Biophys Res Commun 431 2013 617 622
19. D. Liu, Y. Yang, Q. Liu, and J. Wang Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells Med Oncol 28 2011 105 111
20. J.H. Ren, W.S. He, L. Nong, Q.Y. Zhu, K. Hu, and R.G. Zhang et al. Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy Cancer Biother Radiopharm 25 2010 75 80
21. Y. Chang, W. Yan, X. He, L. Zhang, C. Li, and H. Huang et al. miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions Gastroenterology 143 2012 177 187 e178
22. L.B. Frankel, J. Wen, M. Lees, M. Hoyer-Hansen, T. Farkas, and A. Krogh et al. microRNA-101 is a potent inhibitor of autophagy EMBO J 30 2011 4628 4641
23. P. Borst, S. Rottenberg, and J. Jonkers How do real tumors become resistant to cisplatin Cell Cycle 7 2008 1353 1359 (Pubitemid 351872573)
24. S. Periyasamy-Thandavan, M. Jiang, Q. Wei, R. Smith, X.M. Yin, and Z. Dong Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells Kidney Int 74 2008 631 640
25. L. Harhaji-Trajkovic, U. Vilimanovich, T. Kravic-Stevovic, V. Bumbasirevic, and V. Trajkovic AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells J Cell Mol Med 13 2009 3644 3654
26. S.F. Su, Y.W. Chang, C. Andreu-Vieyra, J.Y. Fang, Z. Yang, and B. Han et al. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer Oncogene 2012
27. S. Husted, R. Sokilde, L. Rask, S. Cirera, P.K. Busk, and J. Eriksen et al. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells Mol Pharm 8 2011 2055 2062
28. J. Braun, C. Hoang-Vu, H. Dralle, and S. Huttelmaier Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas Oncogene 29 2010 4237 4244
29. A. Ketley, A. Warren, E. Holmes, M. Gering, A.A. Aboobaker, and J.D. Brook The miR-30 microRNA family targets smoothened to regulate hedgehog signalling in zebrafish early muscle development PLoS ONE 8 2013 e65170
30. L.E. Zaragosi, B. Wdziekonski, K.L. Brigand, P. Villageois, B. Mari, and R. Waldmann et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis Genome Biol 12 2011 R64